These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 32202252)
21. Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography. Marani C; Raiola AM; Morbelli S; Dominietto A; Ferrarazzo G; Avenoso D; Giannoni L; Varaldo R; Gualandi F; Grazia D; Lamparelli T; Bregante S; Van Lint MT; Ibatici A; Bovis F; Lemoli RM; Gobbi M; Bacigalupo A; Angelucci E Biol Blood Marrow Transplant; 2018 Dec; 24(12):2501-2508. PubMed ID: 30041010 [TBL] [Abstract][Full Text] [Related]
22. T-cell deplete versus T-cell replete haploidentical hematopoietic stem cell transplantation for sickle cell disease: where are we? Patel DA; Akinsete AM; Connelly JA; Kassim AA Expert Rev Hematol; 2019 Sep; 12(9):733-752. PubMed ID: 31291790 [No Abstract] [Full Text] [Related]
23. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL. Dreger P; Sureda A; Ahn KW; Eapen M; Litovich C; Finel H; Boumendil A; Gopal A; Herrera AF; Schmid C; Diez-Martin JL; Fuchs E; Bolaños-Meade J; Gooptu M; Al Malki MM; Castagna L; Ciurea SO; Dominietto A; Blaise D; Ciceri F; Tischer J; Corradini P; Montoto S; Robinson S; Gülbas Z; Hamadani M Blood Adv; 2019 Feb; 3(3):360-369. PubMed ID: 30723110 [TBL] [Abstract][Full Text] [Related]
24. Donor-derived CD4 Varlet P; Alsuliman T; Trauet J; Demaret J; Labalette M; Yakoub-Agha I Bone Marrow Transplant; 2019 Oct; 54(10):1686-1693. PubMed ID: 30890769 [TBL] [Abstract][Full Text] [Related]
25. Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia. Chellapandian D; Nicholson CL Pediatr Transplant; 2020 Feb; 24(1):e13641. PubMed ID: 31880407 [TBL] [Abstract][Full Text] [Related]
26. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia. How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457 [TBL] [Abstract][Full Text] [Related]
27. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies. Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040 [TBL] [Abstract][Full Text] [Related]
28. Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide. Robinson TM; O'Donnell PV; Fuchs EJ; Luznik L Semin Hematol; 2016 Apr; 53(2):90-7. PubMed ID: 27000732 [TBL] [Abstract][Full Text] [Related]
29. Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure. Knüppel E; Medinger M; Stehle G; Infanti L; Halter J; Burkhalter F; Mujagic E; Heim D; Passweg J Ann Hematol; 2017 Apr; 96(4):703-705. PubMed ID: 28160086 [No Abstract] [Full Text] [Related]
30. Blood and marrow transplantation for sickle cell disease: is less more? Bolaños-Meade J; Brodsky RA Blood Rev; 2014 Nov; 28(6):243-8. PubMed ID: 25217413 [TBL] [Abstract][Full Text] [Related]
31. Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease. Aumann MA; Richerson W; Song AK; Davis LT; Pruthi S; Davis S; Patel NJ; Custer C; Kassim AA; DeBaun MR; Donahue MJ; Jordan LC Blood Adv; 2024 Feb; 8(3):608-619. PubMed ID: 37883803 [TBL] [Abstract][Full Text] [Related]
32. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India. Uppuluri R; Sivasankaran M; Patel S; Swaminathan VV; Ramanan KM; Ravichandran N; Ramakrishnan B; Jayakumar I; Vaidhyanathan L; Raj R J Clin Immunol; 2019 Feb; 39(2):182-187. PubMed ID: 30778805 [TBL] [Abstract][Full Text] [Related]
33. Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis. Castagna L; Mussetti A; Devillier R; Dominietto A; Marcatti M; Milone G; Maura F; de Philippis C; Bruno B; Furst S; Blaise D; Corradini P; Montefusco V Biol Blood Marrow Transplant; 2017 Sep; 23(9):1549-1554. PubMed ID: 28499937 [TBL] [Abstract][Full Text] [Related]
34. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis. Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951 [TBL] [Abstract][Full Text] [Related]
35. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor. Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000 [TBL] [Abstract][Full Text] [Related]
36. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome. Yue Y; Shi X; Song Z; Qin J; Li J; Feng S; Liu R Pediatr Blood Cancer; 2018 Aug; 65(8):e27092. PubMed ID: 29745014 [TBL] [Abstract][Full Text] [Related]
37. Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Martínez C; Gayoso J; Canals C; Finel H; Peggs K; Dominietto A; Castagna L; Afanasyev B; Robinson S; Blaise D; Corradini P; Itälä-Remes M; Bermúdez A; Forcade E; Russo D; Potter M; McQuaker G; Yakoub-Agha I; Scheid C; Bloor A; Montoto S; Dreger P; Sureda A; J Clin Oncol; 2017 Oct; 35(30):3425-3432. PubMed ID: 28846465 [TBL] [Abstract][Full Text] [Related]
38. Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome. Kanda-Kato M; Yoshioka S; Ishikawa T Case Rep Oncol; 2020; 13(2):1053-1058. PubMed ID: 33082748 [TBL] [Abstract][Full Text] [Related]
39. Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation. Kanate AS; Szabo A; Raj RV; Bower K; Grulke R; Shah N; Ross KG; Cumpston A; Craig M; Pasquini MC; Shah N; Hari P; Hamadani M; Chhabra S Biol Blood Marrow Transplant; 2019 Jul; 25(7):1456-1464. PubMed ID: 30878605 [TBL] [Abstract][Full Text] [Related]
40. Post transplant cyclophosphamide based haplo-identical transplant versus umbilical cord blood transplant; a meta-analysis. Poonsombudlert K; Kewcharoen J; Prueksapraopong C; Limpruttidham N Jpn J Clin Oncol; 2019 Oct; 49(10):924-931. PubMed ID: 31265729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]